The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM wants world vaccinated by end of 2022 for global lockdown escape

Sun, 06th Jun 2021 10:04

(Alliance News) - UK Prime Minister Boris Johnson will urge G7 leaders to "defeat Covid" by vaccinating the world by the end of next year, as he pushes for a global watch system to catch new variants before they can plunge countries back into lockdown.

Johnson is set to stress the importance of the global vaccine programme when he meets with world leaders – including US President Joe Biden – on Friday in Cornwall for the first face-to-face G7 meeting since the pandemic hit.

Setting the scene before their gathering in Carbis Bay on June 11-13, Johnson is calling on his counterparts to "rise to the greatest challenge of the post-war era" by "vaccinating the world by the end of next year", in a move he said would be the single greatest feat in medical history.

It comes as Covid-19 cases have continued to surge in the UK amid reports the prime minister is considering delaying his target of lifting all restrictions in England on June 21 by at least two weeks in order to allow more people to be fully vaccinated.

Johnson said: "I'm calling on my fellow G7 leaders to join us to end this terrible pandemic and pledge we will never allow the devastation wreaked by coronavirus to happen again."

No 10 said the prime minister will tell his counterparts that the world's biggest economies must lower barriers to the international distribution of vaccines and share surplus doses with developing countries bilaterally and through Covax, the United-Nations backed scheme aiming to supply low and medium income countries with jabs.

The Sunday Times reported that the Conservative Party leader is preparing to hand over 100 million vaccine doses to developing countries, donating GBP2 billion worth of jabs this year to the worldwide push to vaccinate every human against Covid-19.

Most of the jabs will be batches of the Oxford University and AstraZeneca PLC vaccine, the newspaper said.

The UK pledged in February to give surplus doses to Covax but has yet to donate any of the 400 million it has on order, with Health Secretary Matt Hancock arguing that there are no excess jabs available given the NHS's own vaccine programme is still in full swing.

Separately, the UK government has been told plans to cut foreign aid from 0.7% of national income to 0.5% could undermine its credibility at the G7 in a letter from charities including Oxfam, Save the Children and WWF UK which has been seen by the BBC.

The government has blamed economic damage caused by the Covid-19 pandemic for its decision to cut aid spending and expects just under GBP10 billion to be allocated to departments for aid spending in 2021/22.

As part of the UK's G7 presidency, officials said the prime minister will encourage support for a global pandemic radar, a surveillance system that will aim to detect vaccine-resistant variants before they have the chance to spread.

Downing Street argued that the UK had "led efforts to ensure the world's poorest and most vulnerable people have access to vaccines", referencing the part played by the Westminster Government in funding the Oxford/AstraZeneca jab.

With the jab made available at cost, No 10 said almost one in three shots administered around the world have been the Oxford vaccine, with 96% of the 80 million shots administered by Covax supplied by AstraZeneca.

Officials also highlighted the "significant financial contribution" of GBP548 million given to Covax in its early formation.

G7 leaders will arrive in Cornwall's Carbis Bay on Friday for three days of meetings, with a focus on how the group, which includes the US and Germany, can lead the global recovery from coronavirus, officials said.

During the sessions the leaders – including those from Canada, Japan, France and Italy – will be joined virtually by experts, including the UK's chief scientific adviser Patrick Vallance, philanthropist Melinda French Gates and environmentalist David Attenborough.

On Saturday, the G7 countries will be joined either in person or virtually by the leaders of Australia, South Africa, South Korea and India for discussions on health and climate change.

It comes as the experts warned against England fully unlocking in little over two weeks' time due to growing concern that the Indian variant, also known as the Delta strain, is pushing cases up.

Of the 12,431 Indian variant cases so far confirmed in the UK, 10,797 are in England, 1,511 in Scotland, 97 in Wales and 26 in Northern Ireland.

Professor Stephen Reicher, a member of the Scientific Pandemic Insights Group on Behaviours, which advises the government, said scrapping all Covid restrictions later this month would be "foolish" and a "major risk".

A UK government spokeswoman said "no decision" had been made on whether to ease all coronavirus restrictions on June 21.

By Patrick Daly, PA Political Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.